| scholarly article | Q13442814 |
| P50 | author | Isei Tanida | Q56088822 |
| Naoya Sakamoto | Q89436415 | ||
| P2093 | author name string | Takashi Ueno | |
| Sumio Watanabe | |||
| Yoshiyuki Takei | |||
| Eiki Kominami | |||
| Kenichi Ikejima | |||
| Nobuyuki Enomoto | |||
| Tsuneo Kitamura | |||
| Tatsuo Sakai | |||
| Shunhei Yamashina | |||
| Tomokazu Mizui | |||
| P2860 | cites work | Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein | Q24319002 |
| Autophagy in the eukaryotic cell | Q24532252 | ||
| Chloroquine is a potent inhibitor of SARS coronavirus infection and spread | Q24815979 | ||
| Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs | Q27472783 | ||
| Therapeutic issues in HIV/HCV-coinfected patients | Q27481053 | ||
| Formation of the Arterivirus Replication/Transcription Complex: a Key Role for Nonstructural Protein 3 in the Remodeling of Intracellular Membranes | Q27485747 | ||
| Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response | Q27487012 | ||
| Autophagy as a regulated pathway of cellular degradation | Q29547914 | ||
| 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes | Q29617843 | ||
| Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles | Q33604281 | ||
| Effects of chloroquine on viral infections: an old drug against today's diseases? | Q33973620 | ||
| The molecular mechanism of autophagy | Q34520654 | ||
| Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons | Q34565853 | ||
| New therapies for chronic hepatitis C virus infection | Q35628143 | ||
| Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages | Q36205312 | ||
| Drug resistance in antiviral treatment for infections with hepatitis B and C viruses | Q36832325 | ||
| Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells | Q40425026 | ||
| Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha | Q40576649 | ||
| Coronavirus replication complex formation utilizes components of cellular autophagy | Q40603146 | ||
| Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity | Q40769773 | ||
| PKR--a protein kinase regulated by double-stranded RNA. | Q41647401 | ||
| Acidotropic amines inhibit proteolytic processing of flavivirus prM protein | Q41745865 | ||
| Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks | Q41912825 | ||
| Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity--formation of crinosomes | Q41912944 | ||
| Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion | Q41915360 | ||
| Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. | Q41917540 | ||
| Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1. | Q41927429 | ||
| Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells | Q42819054 | ||
| Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads | Q42982601 | ||
| Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis | Q43001248 | ||
| Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study | Q43036320 | ||
| Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival | Q45334756 | ||
| Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C. | Q50571426 | ||
| [Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus] | Q50897100 | ||
| Autolysosomal Membrane-associated Betaine Homocysteine Methyltransferase | Q57662999 | ||
| P433 | issue | 2 | |
| P921 | main subject | hepatitis C | Q154869 |
| autophagy | Q288322 | ||
| chloroquine | Q422438 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 195-203 | |
| P577 | publication date | 2009-09-17 | |
| P1433 | published in | Journal of Gastroenterology | Q15764399 |
| P1476 | title | Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy | |
| P478 | volume | 45 |
| Q40593359 | Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model |
| Q64106112 | Autophagy and Noroviruses |
| Q90268717 | Autophagy is involved in assisting the replication of Bamboo mosaic virus in Nicotiana benthamiana |
| Q35196680 | Bovine viral diarrhea virus infection induces autophagy in MDBK cells |
| Q94596745 | COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus |
| Q35071429 | Changes in autophagic response in patients with chronic hepatitis C virus infection |
| Q26828727 | Curing a viral infection by targeting the host: the example of cyclophilin inhibitors |
| Q42248573 | Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women |
| Q34003896 | ER stress, autophagy, and RNA viruses |
| Q37107125 | Functions of autophagy in normal and diseased liver |
| Q96768625 | Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? |
| Q33794114 | HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains |
| Q36298491 | HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy |
| Q36652533 | Hepatitis C virus and autophagy |
| Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
| Q39241528 | Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy |
| Q36172124 | Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. |
| Q26779128 | Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection |
| Q55280981 | Host-targeting therapies for hepatitis C virus infection: current developments and future applications. |
| Q38113944 | How positive-strand RNA viruses benefit from autophagosome maturation |
| Q37252935 | Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus |
| Q37985470 | Interplay between the cellular autophagy machinery and positive-stranded RNA viruses |
| Q35910776 | Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes |
| Q38205866 | Modulation of autophagy for the treatment of liver diseases. |
| Q35914270 | New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. |
| Q90327245 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| Q40747582 | New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial). |
| Q35052848 | Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds |
| Q36002897 | Replication of hepatitis C virus RNA on autophagosomal membranes |
| Q34878438 | Role of autophagy in liver physiology and pathophysiology |
| Q39360987 | Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |
| Q60031638 | The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions |
| Q92633499 | The Use of Antimalarial Drugs against Viral Infection |
| Q39205134 | The antimalarial ferroquine is an inhibitor of hepatitis C virus. |
| Q96110593 | The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway |
| Q94590927 | Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review |
| Q27333686 | Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses |
| Q37957297 | Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development |
| Q34430095 | West Nile virus (WNV) replication is independent of autophagy in mammalian cells |
| Q38735359 | Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV. |
| Q38893853 | p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer |
| Q27644656 | p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming |
Search more.